
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The efficacy of immune checkpoint inhibitors was found in patients with both HIV and non–small cell lung cancer (NSCLC), though more inclusion of people with HIV is needed in future studies.

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment.

Patients with diabetic macular edema (DME) using faricimab had durable results after 1 year in real-world practice.

Confusion around how to verify work hours could leave millions unenrolled after the passing of the One Big Beautiful Bill Act.

Using artificial intelligence (AI) to specialize treatment for patients with different kinds of cancer can be a boon to clinicians looking to personalize their care.

Young and frequently incarcerated individuals living with HIV require discharge planning and post release support to maintain viral suppression outcomes.

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best therapeutic options for patients with cancer.

Individuals with both low incomes and health problems were more likely to gain employment when covered by Medicaid.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Measles vaccinations and preparation can prevent significant strain on financial and public health systems in the country.

Children and adults should watch where they are walking and avoid any thrown objects when participating in Halloween festivities to protect their eyes.

Comparable overall survival and distant recurrence outcomes make stereotactic body radiation a feasible alternative.

Symptoms of dry eye improved when patients in Canada used reproxalap compared with a placebo dose.

Researchers found more local pharmacies than facilities that prescribed pre-exposure prophylaxis (PrEP) in areas of high case load.

Panels held throughout the conference emphasized both how far the specialization has come but also how far it has yet to go.

Any injury to the eye, like those acquired during trick-or-treating, should be seen by an eye doctor if it does not resolve within a day.

Using masks that tie up in the back and being aware of environmental factors can help protect eyes during Halloween trick-or-treating.

Meta-analyses presented at the CHEST 2025 Annual Meeting find that combinations that include amivantamab and nivolumab improved overall and progression-free survival in non–small cell lung cancer (NSCLC).

The efficacy of GLP-1 inhibitors in weight loss has introduced them as a means of also addressing obstructive sleep apnea in sleep medicine.

A session held during the CHEST 2025 Annual Meeting focused on the North American guidelines for treating bronchiectasis.

Phenotyping patients can help to identify potential heart failure with preserved ejection fraction (HFpEF) as well as improve patient outcomes.

Guidelines that encouraged the exposure of peanuts in children were found to significantly reduce food allergies.

Intensivists gathered at the CHEST 2025 Annual Meeting to discuss how climate change is affecting and will affect their practice of treating pulmonary conditions.

Results from the ASPEN trial also show that brensocatib displayed several benefits when used in patients with bronchiectasis, including a reduction in symptom burden.

Education on birth control and its potential adverse effects is vital to women choosing the type that best suits them.

Panels at the conference include coverage of new guidelines, the use of AI in pulmonary care, and progress on respiratory vaccines.

Face paint offers fewer chances at eye injury along with more freedom of movement when dressing up for Halloween.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Women who received the mRNA COVID-19 vaccine in their first trimester did not have an increased risk of their child having a major congenital malformation.

Published: October 19th 2025 | Updated: October 22nd 2025

Published: August 18th 2025 | Updated: August 25th 2025

Published: August 19th 2025 | Updated: August 22nd 2025

Published: September 26th 2024 | Updated: October 1st 2024

Published: March 21st 2025 | Updated:

Published: March 12th 2025 | Updated:

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
